logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11414666 B1

PDFFull Text
Date of Patent:
Aug. 16, 2022

Filed:

Jun. 23, 2017

Viral vectors for treating neurogenic detrusor overactivity

Applicants:

Universite DE Versailles-st Quentin En Yvelines, Versailles, FR;

Assistance Publique—hopitaux DE Paris, Paris, FR;

Inventors:

François Giuliano, Paris, FR;

Alberto Epstein, Montigny-le-Bretonneux, FR;

Olivier Le Coz, Le Mesnil saint denis, FR;

Alejandro Aranda, Pamplon, ES;

Assignees:

UNIVERSITE DE VERSAILLES-ST QUENTIN EN YVELINES, Versailles, FR;

ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, Paris, FR;

Attorney:

Birch, Stewart, Kolasch & Birch, LLP

Primary Examiner:

James D Schultz

Assistant Examiner:

James Joseph Graber

Int. Cl.
CPC ...
A61K 38/16 (2006.01); A61P 13/00 (2006.01); A61K 38/48 (2006.01); C12N 15/869 (2006.01); C12N 15/113 (2010.01); A61P 13/06 (2006.01); A61K 38/17 (2006.01); A61K 38/45 (2006.01); A61K 38/51 (2006.01); C12N 15/86 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1138 (2013.01); A61K 38/164 (2013.01); A61K 38/1793 (2013.01); A61K 38/45 (2013.01); A61K 38/4893 (2013.01); A61K 38/51 (2013.01); A61P 13/06 (2018.01); C12N 15/86 (2013.01); C12Y 304/24069 (2013.01); C12Y 401/01015 (2013.01); C12N 2310/11 (2013.01); C12N 2320/31 (2013.01); C12N 2320/32 (2013.01); C12N 2710/16643 (2013.01); C12N 2830/008 (2013.01); C12N 2830/40 (2013.01);
Abstract

The present invention provides a method and a pharmaceutical composition for the treatment of the NDO comprising the viral expression vector carrying a transcription cassette that harbors transgene(s) inhibiting/silencing neurotransmission or synaptic transmission of afferent neurons.

Find Patent Forward Citations

Giuliano, François. (2022). Viral vectors for treating neurogenic detrusor overactivity (U.S. Patent No. 11414666). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11414666

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…